Reaction
Renal Graft Infection reporting signals
As of the last recalculation, Renal Graft Infection appears in 229 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 756.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 195 | 756.4 | 757.4 |
| Tacrolimus Ointment 0.1% | 181 | 626.5 | 627.4 |
| Tacrolimus Extended-Release Capsules | 181 | 624.8 | 625.7 |
| Basiliximab | 43 | 408.9 | 410.4 |
| Mycophenolate Mofetil | 144 | 257.9 | 258.2 |
| Mycophenolate Mofetil Hydrochloride | 144 | 257.5 | 257.7 |
| Anti-Thymocyte Globulin (Rabbit) | 19 | 233.4 | 233.9 |
| Valganciclovir Hydrochloride Powder, | 24 | 199.7 | 200.1 |
| Sirolimus | 21 | 155.9 | 156.1 |
| Valganciclovir | 26 | 141.3 | 141.5 |
| Valganciclovir Hydrochloride | 26 | 141.3 | 141.5 |
| Cefuroxime | 11 | 91.8 | 91.9 |
| Mycophenilic Acid | 17 | 80.5 | 80.5 |
| Mycophenolic Acid | 25 | 79.6 | 79.6 |